1. X
  2. Osmind
Log inSign up
Osmind
1,141 posts
Image
user avatar
Osmind
@OsmindHQ
The premier technology platform for breakthrough mental health treatment and research.
San Francisco, CA
osmind.org
Joined May 2020
373
Following
955
Followers
RepliesRepliesMediaMedia

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
  • Pinned
    user avatar
    Osmind
    @OsmindHQ
    May 4, 2024
    Replying to @OsmindHQ
    Learn more about our collaboration with the APA:
    Image
    APA collaboration on precision psychiatry tools | Osmind
    From osmind.org
    915
  • user avatar
    Osmind
    @OsmindHQ
    Jul 29
    The FDA approved Viagra in 1998. It took another 17 years to approve the first drug for low sexual desire in premenopausal women, and Anita Clayton, MD, spent much of that time challenging how medicine studied women’s sexual health. When fluoxetine’s label reported sexual
    Image
    Antidepressant Sexual Dysfunction and Women's Health with Anita Clayton, MD | Osmind
    From osmind.org
    71
  • user avatar
    Osmind
    @OsmindHQ
    Jul 15
    200 miles from the nearest major city, Cassi Heuer opened a psychiatry practice in her hometown of 14,000 – nobody else had. "It was very important for me to bring back care to my community that I didn't feel like was available or easily accessible when I was growing up."
    Image
    Made with AI
    98
  • user avatar
    Osmind
    @OsmindHQ
    Jul 1
    Wondering how to reduce your SPRAVATO® drug costs? Join CareNet GPO inside the Psychiatry Collective Tuesday, Jul 7th, 09:00 AM - 10:00 AM PDT to learn: •How CareNet GPO membership unlocks reduced SPRAVATO® pricing •The set-up process, step by step •SPRAVATO® practice
    62
  • user avatar
    Osmind
    @OsmindHQ
    Jun 23
    What happens when depression persists despite multiple treatment attempts? Chief Medical Officer, William Sauvé, MD, and Health Management Associates Principal Mark Desmarais discuss the access, clinical, and policy challenges patients face with treatment-resistant depression.
    Image
    Made with AI
    58
  • See @OsmindHQ's full profile

    Sign up
    Log in
Advertisement
Advertisement